Kidd, Brian A
Wroblewska, Aleksandra
Boland, Mary R
Agudo, Judith
Merad, Miriam
Tatonetti, Nicholas P
Brown, Brian D
Dudley, Joel T
Article History
Received: 7 February 2015
Accepted: 11 August 2015
First Online: 1 January 2016
Competing interests
: B.A.K. has received consulting fees from Merck. J.T.D. owns equity in NuMedii Inc. and has received consulting fees or honoraria from Janssen Pharmaceuticals, GlaxoSmithKline, AstraZeneca and LAM Therapeutics.